Pharm Flashcards

1
Q

explain pharmacokinetics and pharmacodynamics.
what is the effect on drugs reaching their site of action?

A

pharmacokinetics: what the body does to the drug
– absorbs, metabolizes, excreted

pharmacodynamics: what the drug does to the body
– decreases pain, lower BP, improve function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

distinguish chemical, generic and trade/brand names

A

chemical: N-acetyl-p-aminophenol
generic name (shortened chemical name): acetaminophen
trade/brand name: tylenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

steps of FDA testing and approval

A
  1. preclinical (animal) trials: 1-2 years
  2. clinical trials:
    – phase 1: healthy volunteers <1 year
    – phase 2: small patient sample 2 years
    – phase 3: larger sample 3 years
  3. approved for marketing
  4. post-marketing surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

odds of drug approval

A

for every 5,000 compounds that enter preclinical trials, 1 is approved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

implications of drug testing/approval

A

drug costs
availability in US (looks at safety & efficacy) vs other countries (only look at safety)
failure to identify serious side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

off label prescribing

A

prescription of a drug for a purpose that has not been approved by the FDA
40-60% of all prescriptions
legal? yes, FDA can’t tell physician how to practice medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dose-response relationship

A

no response if dose is too low
response appears at some “threshold” dose
response increases as dose increases until response plateaus (maximal efficacy/ceiling effect)
* dose-response curve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

potency

A

related to the dose that causes a specific response in a specific magnitude
- drug that causes response at lower dose = more potent

  • potency does not mean more effective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

therapeutic index

A

indicates drugs safety
higher TI = safer the drug
TI = dose w/ toxic effect / dose w/ benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is an acceptable TI?

A

no fixed guidelines
some drugs may have a lower number and produce serious side effects but the benefit outweighs the side effects (i.e. cancer drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the ADME stand for in pharmacokinetics?

A

absorption
distribution
metabolism
excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

absorption of pharmaceutical agents

A

drugs that typically move from site of administration into another tissue or central component (bloodstream)
directly related to route of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the two routes of administration?

A

enteral (oral, lingual, buccal, rectal)
– fairly simple, easy, less predictable absorption (lots of hurdles)

parenteral (injection, inhalation, topical, transdermal, others)
– more difficult, inconvenient, more predictable absorption (administered at site)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

bioavailability

A

percent of administered dose that appears in bloodstream
ex: if 100 mg taken orally and 50 mg appear in bloodstream –> 50% bioavailable
– 100% bioavailable if given IV

some of the drug is destroyed during the “first pass” thru the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

distribution of pharmaceutical agents

A

drugs cross membranes and tissues to reach target site
affected by:
administration route
physicochemical properties of drug
binding to plasma proteins
various barriers and carriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

volume of distribution

A

Vd = amount of drug administered / concentration in plasma

Vd = 42 –> even distribution throughout body
Vd < 42 –> drug retained in plasma
Vd > 42 –> drug retained in tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

metabolism of pharmaceutical agents aka biotransformation

A

active form of drug is changed chemically to an inactive or less active byproduct or metabolite
creates a more polar, water soluble metabolite that can be excreted by kidneys

primary site of metabolism: liver
others: lungs, kidneys, GI tract, skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

enzymes metabolize the drug via;

A

phase 1 rxns: oxidation
phase 2 rxns: conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

excretion of pharmaceutical agents: sites

A

primary site: kidneys
other significant sites: lungs, GI tract
minor sites: sweat, saliva, breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

excretion of pharmaceutical agents

A

kidneys usually excrete metabolites after biotransformation in liver, other organs
25-30% drugs excreted “intact”
urine pH can affect excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how will some physical therapy interventions affect pharmacokinetics?

A

timing of rehab session with drug peaks and troughs (related to how pt feels during session)
effects on absorption/distribution:
– increased by heat, exercise, massage
– decreased by cold
help recognize improper drug responses (we get them doing things they’re normally not doing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

analgesics vs anti-inflammatory agents
examples of opioids vs nonopioids

A

analgesics:
- opioids = morphine
- nonopioids = NSAIDS, acetaminophen

23
Q

opioids:

A

alter pain perception
used in moderate-severe pain
indicated in: acute and chronic pain

24
Q

types of opioids:
agonists = stimulates receptors
antagonists = block receptors

A

strong agonists: morphine, meperidine, fentanyl
moderate agonists: codeine, oxycodone
antagonists: naloxone, nalmefene
mixed agonist/antagonists: butorphanol, nalbuphine, pentazocine

25
opioid mechanism of action:
act primarily on spinal cord and brain bind to specific receptors located on presynaptic nerve terminals and postsynaptic neurons
26
opioids can affect:
peripheral (sensory) neurons: decrease sensitivity of neuron that initiates painful impulse descending (efferent) pathways: remove inhibition of central anti-pain circuits (pain signal)
27
opioid adverse effects:
minor: - sedation - mood changes - confusion - N&V - constipation major: - orthostatic hypotension - respiratory depression - tolerance, dependence, addiction
28
opioid tolerance
need more drug to achieve same effect begins: after 1st dose obvious after: 2-3 weeks lasts: 1-2 weeks after opioid discontinued
29
physical dependence
onset of withdrawal if drug suddenly stopped withdrawal can begin: 6-10 hours after last dose, peak within 2-3 days symptoms last 5 days
30
can patients go through withdrawal and not be addicted?
yes
31
opioid withdrawal symptoms
body aches gooseflesh fever, shivering N&V, diarrhea, cramps, irritability uncontrollable yawning weakness/fatigue leg cramps sneezing, runny nose loss of appetite sweating tachycardia
32
addiction
chronic, relapsing disease characterized by compulsive drug seeking and use despite negative consequences and by long-lasting changes in the brain
33
risk of opioid addiction during short term use
risk of addiction after surgery or trauma is low if: - used for limited period of time (3-7 days) - dosage matches patient's pain - no history of substance abuse - pt does not misuse opioid
34
risk of misuse and addiction in patients with chronic pain
chronic use is > 90 days misuse = 21-29% pts addiction = 8-12% majority do not experience addiction unless misuse occurs
35
rehab concerns with opioids
be alert for orthostatic hypotension monitor signs of respiratory depression monitor pain levels watch for signs of abuse/overdose
36
primary effects of NSAIDS
analgesic anti-inflammatory antipyretic anticoagulant anticancer?
37
OTC vs prescription NSAIDS
OTC: - aspirin - ibuprofen - naproxen - ketoprofen prescription: - etodolac - fenoprofen - ketorolac - meclofenamate - piroxicam
38
NSAIDS: MOA
inhibit synthesis of prostaglandins (lipid compounds produced in cell) by inhibiting cyclooxygenase
39
rehab concerns with NSAIDS:
irritate stomach damage to liver or kidneys increases BP, risk of MI/stroke impaired bone and cartilage healing overdose inform patients that NSAID does not equal acetaminophen
40
COX-2
induced when cell is injured synthesizes PGs that mediate pain, inflammation spare production of beneficial PGs in stomach, kidney, platelets may decrease pain and inflammation with less toxicity ex: celecoxib
41
COX-2 inhibition
promotes infarction caused by heart attack, stroke
42
why does COX-2 inhibition promote infarction?
normally: PGs that cause vasodilation and vasoconstriction are in balance COX-2 selective drugs preferentially inhibit vasodilating PGs; spare production of COX1 PGs that cause constriction and platelet aggregation increased constriction and platelet activity shifts balance toward infarction
43
Acetaminophen
antipain and anti fever effects no GI irritation no anti-inflammatory or anticoagulant effects high doses: liver toxicity
44
anti-inflammatory steroids
steroids with powerful anti-inflammatory and immunosuppressive effects resolve inflammation
45
anti-inflammatory steroid administration methods
oral, systemic (regular, dose packs) injection inhalation, topical, nasal, ophthalmic
46
anti-inflammatory steroids rehab concerns
primary problem: catabolic effect on bone, muscle, ligament, tendon, skin other side effects: water/salt retention, increased infection, gastic ulcers, glucose intolerance, glaucoma, adrenal suppression
47
adrenocortical shock
why you can't suddenly stop taking anti-inflammatory steroids vascular collapse, severe hypotension, organ damage can be fatal
48
primary goal of all muscle relaxants primary use
goal: selective decrease in skeletal muscle excitability uses: muscle spasms and spasticity
49
muscle spasms
injury usually to muscle, peripheral nerve tonic contraction in paraspinals, traps, etc
50
used to treat muscle spasms:
centrally-acting antispasm drugs - commonly in back, neck spasms, ortho injuries diazepam (valium)
51
muscle spasms MOA
carisoprodol: enhances GABA inhibition in brain cyclobenzaprine: might increase serotonin in brainstem strong sedatives
52
diazepam (valium)
anti anxiety drug works in CNS increases inhibitory effects of GABA: inhibitory neurotransmitter with receptors in brain, spinal cord
53
diazepam (valium): how it affects PT
valium increases GABA mediated inhibition of alpha motor neuron less excitation leads to muscle relaxation used in spasms and spasticity but also causes sedation